
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
Jonathan I. Silverberg, Melinda Gooderham, Amy S. Paller, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 485-496
Open Access | Times Cited: 6
Jonathan I. Silverberg, Melinda Gooderham, Amy S. Paller, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 485-496
Open Access | Times Cited: 6
Showing 6 citing articles:
Identification of a dual JAK3/TEC family kinase inhibitor for atopic dermatitis therapy
Y.C. Du, Longling Wang, Jingmei Zhou, et al.
Biochemical Pharmacology (2025) Vol. 232, pp. 116740-116740
Closed Access
Y.C. Du, Longling Wang, Jingmei Zhou, et al.
Biochemical Pharmacology (2025) Vol. 232, pp. 116740-116740
Closed Access
Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre Study
Stamatios Gregoriou, Ioannis‐Alexios Koumprentziotis, Ileana Afroditi Kleidona, et al.
Dermatology and Therapy (2025)
Open Access
Stamatios Gregoriou, Ioannis‐Alexios Koumprentziotis, Ileana Afroditi Kleidona, et al.
Dermatology and Therapy (2025)
Open Access
Advancements in pharmacological interventions for atopic dermatitis current strategies and future directions
Yan Zhang, Shaoying Yuan, Yixing Wu, et al.
Inflammopharmacology (2025)
Closed Access
Yan Zhang, Shaoying Yuan, Yixing Wu, et al.
Inflammopharmacology (2025)
Closed Access
Systemtherapie der AD
Thomas Werfel
hautnah dermatologie (2025) Vol. 41, Iss. S1, pp. 6-15
Closed Access
Thomas Werfel
hautnah dermatologie (2025) Vol. 41, Iss. S1, pp. 6-15
Closed Access
Biologics Versus JAK Inhibitors. Part I: Cancer Risk. A Narrative Review
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 6, pp. 1389-1442
Open Access | Times Cited: 3
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 6, pp. 1389-1442
Open Access | Times Cited: 3
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Week 16 results of an Open-label, Randomized, Efficacy Assessor-Blinded Head-to-Head Phase 3b/4 Study (Level Up)
Jonathan I. Silverberg, Christopher G. Bunick, Hwanhee Hong, et al.
British Journal of Dermatology (2024)
Open Access | Times Cited: 1
Jonathan I. Silverberg, Christopher G. Bunick, Hwanhee Hong, et al.
British Journal of Dermatology (2024)
Open Access | Times Cited: 1